Handelsbanken Fonder’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2M Buy
301,041
+185,200
+160% +$20.1M 0.13% 125
2026
Q1
$10.7M Buy
115,841
+82,200
+244% +$8.25M 0.04% 361
2025
Q4
$3.44M Buy
33,641
+4,000
+13% +$358K 0.01% 576
2025
Q3
$1.85M Hold
29,641
0.01% 753
2025
Q2
$1.54M Sell
29,641
-3,100
-9% -$138K 0.01% 759
2025
Q1
$1.4M Buy
32,741
+3,800
+13% +$164K 0.01% 804
2024
Q4
$884K Buy
28,941
+1,800
+7% +$50.6K ﹤0.01% 1026
2024
Q3
$623K Buy
27,141
+3,500
+15% +$99.1K ﹤0.01% 1149
2024
Q2
$683K Sell
23,641
-208,700
-90% -$4.86M ﹤0.01% 1014
2024
Q1
$4.79M Buy
232,341
+71,000
+44% +$1.52M 0.02% 453
2023
Q4
$4.36M Buy
161,341
+38,900
+32% +$1.02M 0.02% 443
2023
Q3
$3.63M Buy
122,441
+8,341
+7% +$293K 0.02% 453
2023
Q2
$4.08M Buy
114,100
+1,300
+1% +$37.3K 0.02% 445
2023
Q1
$2.64M Hold
112,800
0.02% 491
2022
Q4
$3.07M Buy
112,800
+100
+0.1% +$4.58K 0.02% 474
2022
Q3
$6.07M Hold
112,700
0.04% 374
2022
Q2
$4.55M Buy
112,700
+1,300
+1% +$64.4K 0.03% 437
2022
Q1
$7.38M Buy
111,400
+45,400
+69% +$3.11M 0.04% 391
2021
Q4
$6.6M Sell
66,000
-4,300
-6% -$445K 0.03% 432
2021
Q3
$8.79M Buy
70,300
+1,600
+2% +$190K 0.05% 358
2021
Q2
$8.53M Sell
68,700
-9,500
-12% -$1.28M 0.04% 376
2021
Q1
$11.9M Buy
78,200
+19,700
+34% +$2.98M 0.07% 265
2020
Q4
$7.54M Sell
58,500
-2,600
-4% -$299K 0.05% 334
2020
Q3
$6.83M Buy
61,100
+7,500
+14% +$686K 0.05% 301
2020
Q2
$4.35M Buy
53,600
+10,600
+25% +$854K 0.04% 371
2020
Q1
$2.99M Hold
43,000
0.06% 152
2019
Q4
$3.36M Buy
43,000
+10,000
+30% +$721K 0.06% 163
2019
Q3
$2.11M Sell
33,000
-60,000
-65% -$5.29M 0.04% 165
2019
Q2
$8.03M Buy
+93,000
New +$7.1M 0.15% 142

Other funds holding GH

Handelsbanken Fonder's GH Position: Q2 2026 in Review

Handelsbanken Fonder increased its Guardant Health (GH) stake by 160% in Q2 2026, buying an estimated $20.1M and bringing the position to 301,041 shares worth $45.2M. The position accounts for 0.13% of the portfolio, ranked #125.

Handelsbanken Fonder first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 153 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Handelsbanken Fonder held 301,041 shares of Guardant Health worth $45.2M as of Q2 2026.
  • Handelsbanken Fonder bought 185,200 Guardant Health shares in Q2 2026, an estimated $20.1M.
  • Guardant Health made up 0.13% of Handelsbanken Fonder's portfolio in Q2 2026, its #125 holding.
  • Handelsbanken Fonder first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • 153 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.